What is it? TB-500 is a synthetic version of a naturally occurring 43-amino-acid peptide called Thymosin Beta-4 (Tβ4), which is found in virtually every cell in your body. It plays a central role in tissue repair, cell migration, and inflammation regulation. If BPC-157 is the repair foreman, TB-500 is the supply chain logistics manager — it makes sure the right cells get to the right place. How does it work? TB-500's primary mechanism revolves around its ability to upregulate actin, a cell-building protein that's critical for cell structure and movement. When tissue is damaged, cells need to migrate to the injury site, proliferate, and rebuild. Actin is the scaffolding that makes this possible. Here's the analogy: imagine a highway system after a natural disaster. Roads are damaged, emergency vehicles can't get through, and rebuilding crews are stuck in traffic. TB-500 essentially rebuilds the roads — it reorganizes the cellular infrastructure so that healing cells can actually reach the damage and get to work. Beyond actin regulation, TB-500 also: • Promotes angiogenesis (new blood vessel formation) — similar to BPC-157 but through different pathways • Reduces inflammatory cytokines, dialing down the excessive inflammation that often slows healing • Promotes cell differentiation, helping stem cells mature into the specific tissue types needed The anti-inflammatory angle is a big deal. Inflammation is necessary for healing, but your body often overdoes it. TB-500 appears to modulate this response — not suppress it entirely, but bring it back into a productive range. What does the research say? Thymosin Beta-4 actually has a stronger clinical research pedigree than many peptides in this space, partly because a pharmaceutical company (RegeneRx Biopharmaceuticals) has been developing it for medical applications: • Cardiac repair: A landmark study published in Nature (Bock-Marquette et al., 2004) demonstrated that Tβ4 promoted cardiac cell survival and improved heart function after coronary artery ligation in mice. This was a big deal — it put Thymosin Beta-4 on the map for serious researchers.

What is it? Semaglutide is a GLP-1 receptor agonist — a synthetic peptide that mimics the hormone GLP-1 (glucagon-like peptide-1), which your body naturally produces after eating. You probably know it by its brand names: Ozempic (for type 2 diabetes) and Wegovy (for weight management). It's the peptide that went from clinical tool to cultural phenomenon practically overnight, and it's reshaped the conversation around obesity treatment in ways we haven't seen in decades. How does it work? After you eat, your gut releases GLP-1, which does a few key things: it tells your pancreas to release insulin, slows gastric emptying (food sits in your stomach longer), and signals to your brain that you're full. The problem is, natural GLP-1 gets broken down by an enzyme called DPP-4 within minutes. Semaglutide is basically GLP-1 that went to the gym. It's been structurally modified with a fatty acid chain that lets it bind to albumin in your blood, protecting it from DPP-4 degradation. Instead of lasting minutes, it lasts about a week. Same key, same lock — it just doesn't break off. Here's the analogy: imagine your appetite is controlled by a thermostat. Normally, eating sends a signal that turns the temperature down (reduces hunger). But that signal fades quickly and the thermostat creeps back up. Semaglutide is like installing a smarter thermostat that holds the set point lower for a full week. You're not fighting your hunger with willpower — the signal that says "I'm satisfied" just stays on longer. The brain component is significant. Semaglutide crosses the blood-brain barrier and acts on GLP-1 receptors in the hypothalamus, directly reducing appetite and food cravings. This is why people on semaglutide often report not just eating less, but genuinely wanting less. The "food noise" goes quiet. What does the research say? This is where semaglutide is in a completely different league from other peptides in this list. We're not talking about rat studies — we're talking about massive, multi-year, FDA-reviewed clinical trials: